New registry data presented at #EACTS2026 suggest the survival benefit favoring #TAVI over #SAVR in DEDICATE-DZHK6 may be less pronounced outside the trial setting. https://bit.ly/4hNlcaR
@tctmd.bsky.social@tctmd.bsky.social
@tctmd.bsky.socialNew registry data presented at #EACTS2026 suggest the survival benefit favoring #TAVI over #SAVR in DEDICATE-DZHK6 may be less pronounced outside the trial setting. https://bit.ly/4hNlcaR